NCT06322927Completed
PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
This is a qualitative (interview) study to explore the experiences of people receiving treatment for MM and to understand what matters most to participants when making treatment decisions.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 9 (actual)
- First submitted
- 14 Mar 2024
- Start date
- 5 Apr 2024
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- The Christie NHS Foundation Trust
- Diseases
- Multiple myeloma
- NCT number
- NCT06322927
What you commit to
- Study type: Observational
- Participants enrolled: 9
- From 5 Apr 2024 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Aged under 18
Other
- Unable to understand and communicate in the English language
- Unable to provide written informed consent
Who the study is looking for
- Participants with confirmed MM (per standard disease specific diagnostic criteria)
- Participants must have received ≥ 5 lines of treatment for MM and fit into one of the below treatment categories:
- Subset 1- Participants must have received an oral anti-cancer therapy and a bi-specific antibody treatment.
- Subset 2- Participants must have received an oral anti-cancer therapy and if they have not had a bi-specific antibody treatment, they must have received at least one IV therapy.
- Aged 18 years of age or over
- Able to provide informed consent
- Able to communicate in English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Christie NHS Foundation Trust Coordinator of this site? Confirm its status | Manchester | United Kingdom | Unknown status |
Related publications
- iPREFER: Patients' Experiences and Preference of Treatment for Multiple Myeloma Following Multiple Lines of Treatment - A Qualitative Study.Patient Prefer Adherence · 2026 · PMID 42080199
This page is information, not medical advice. Discuss any trial with your doctor.